Companion Diagnostics for Oncology Market : Segmented by Product & Service (Product, Service); By Technology (Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Immunohistochemistry (IHC), In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH), Other Technologies); By Disease Type (Breast Cancer, Non-Small Cell Lung Cancer, Colorectal Cancer, Leukemia, Melanoma, Prostate Cancer, Others); By End-use (Hospital, Pathology/Diagnostic Laboratory, Academic Medical Center) and Region - Global Analysis of Market Size, Share & Trends for 2019-2020 and Forecasts to 2030
Next-Generation Sequencing (NGS), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
Immunohistochemistry (IHC), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
Other Technologies, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
By Disease Type: Market Share (2020-2030F)
Breast Cancer, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
Non-Small Cell Lung Cancer, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
Colorectal Cancer, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
Leukemia, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
Melanoma, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
Prostate Cancer, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
By End-use: Market Share (2020-2030F)
Hospitals, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
Pathology/Diagnostic Laboratory, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
Academic Medical Center, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
Company Profile
Agilent Technologies, Inc.
Company Overview
Company Total Revenue (Financials)
Market Potential
Global Presence
Key Performance Indicators
SWOT Analysis
Product Launch
Illumina, Inc.
QIAGEN N.V.
Thermo Fisher Scientific, Inc.
F. Hoffmann-La Roche Ltd.
ARUP Laboratories
Abbott
Myriad Genetics, Inc.
bioMérieux SA
Invivoscribe, Inc.
Consultant Recommendation
**The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.
We have been working with some Fortune 500+ clients
We Respect Your Privacy
Fatpos Global is committed to providing a secure, transparent, and user-friendly browsing experience. To continue improving our website and services, we request your consent for the use of cookies. Below are the types of cookies we utilize:
These cookies are required for the website to operate smoothly and are always enabled. They help maintain core functionalities, remember your basic preferences, and ensure a safe and seamless user experience.
These cookies help us understand how users interact with our content. By analyzing page visits and user engagement, we can continuously refine our platform and deliver more relevant insights, articles, and resources.
These cookies do not collect personally identifiable information. Instead, they recognize your browser or device to display content that may be relevant to your interests on our site or through selected partners, including social media and advertising networks.